Integrative proteogenomic, transcriptomic and structural prioritization of therapeutic targets for anorexia nervosa

Background Anorexia nervosa (AN) lacks an approved pharmacotherapy for its core psychopathology. We aimed to prioritize genetically supported and therapeutically tractable molecular targets. Methods Cis-pQTL instruments were evaluated against the 2017 and 2019 AN GWAS datasets using drug-target Mendelian randomization and Bayesian colocalization. Eight core targets were subsequently examined using sensitivity analyses, pQTL- and eQTL-based SMR/HEIDI, eQTLGen blood data, GTEx v10 brain tissues, pleiotropy annotation, enrichment analysis, protein-interaction networks, druggability annotation and exploratory molecular docking. Results NCAM1 showed the most coherent protein-level evidence, with directionally concordant nominal IVW associations in both AN GWAS datasets and global PP.H4 = 0.726 in PGC2017. CRIM1 showed the most reproducible nominal transcript-level pattern across blood SMR and cerebellar GTEx MR analyses, although neither blood nor brain transcript-level colocalization provided strong evidence for a shared causal variant. CALCA received the highest translational annotation score because of established CGRP-pathway pharmacology; this

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11520215/v1
Primary Topic
Eating Disorders and Behaviors
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Integrative proteogenomic, transcriptomic and structural prioritization of therapeutic targets for anorexia nervosa

Yao Bi, Xiangyun Yang, Zhan-Jiang Li, Peng-Chong Wang et al.
Research Square
Eating Disorders and Behaviors
preprint

Integrative proteogenomic, transcriptomic and structural prioritization of therapeutic targets for anorexia nervosa

Yao Bi, Xiangyun Yang, Zhan-Jiang Li, Peng-Chong Wang, Xu Lin
preprint en

Abstract

Background Anorexia nervosa (AN) lacks an approved pharmacotherapy for its core psychopathology. We aimed to prioritize genetically supported and therapeutically tractable molecular targets. Methods Cis-pQTL instruments were evaluated against the 2017 and 2019 AN GWAS datasets using drug-target Mendelian randomization and Bayesian colocalization. Eight core targets were subsequently examined using sensitivity analyses, pQTL- and eQTL-based SMR/HEIDI, eQTLGen blood data, GTEx v10 brain tissues, pleiotropy annotation, enrichment analysis, protein-interaction networks, druggability annotation and exploratory molecular docking. Results NCAM1 showed the most coherent protein-level evidence, with directionally concordant nominal IVW associations in both AN GWAS datasets and global PP.H4 = 0.726 in PGC2017. CRIM1 showed the most reproducible nominal transcript-level pattern across blood SMR and cerebellar GTEx MR analyses, although neither blood nor brain transcript-level colocalization provided strong evidence for a shared causal variant. CALCA received the highest translational annotation score because of established CGRP-pathway pharmacology; this

Research Square
Beijing Anding Hospital (CN)
Eating Disorders and Behaviors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon